Mediastinal Lymphoma

• CLINICAL_TRIALS trial_result · 2024-01-03
  Clinical Trial Update: Multicenter Study of Safety and Efficacy Nivolumab at the Fixed Dose 40 mg (Nivo40) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed PMBL [Phase 3]

  A multicenter Phase 3 trial evaluating fixed-dose nivolumab (40 mg) in combination with chemo-immunotherapy for newly diagnosed primary medi…

• CLINICAL_TRIALS trial_result · 2022-08-26
  Clinical Trial Update: B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 [Phase 4]

  Phase 4 clinical trial update for a B-cell mature non-Hodgkin lymphoma treatment protocol in children and adolescents; currently recruiting.

• CLINICAL_TRIALS trial_result · 2021-04-19
  Clinical Trial Update: Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients [Phase 1]

  Phase 1/open-label pharmacokinetic study assessing interactions between tazemetostat and CYP enzymes and gastric pH in patients with B-cell …

• CLINICAL_TRIALS trial_result · 2010-10-28
  Clinical Trial Update: Radiotherapy in Primary Mediastinal Lymphoma

  This update reports completion of a clinical trial assessing adjuvant radiotherapy in complete remission patients with primary mediastinal l…